Cash on Hand for Novo Nordisk (NVO)
According to Novo Nordisk's latest reported financial statements, the company's latest reported cash and short-term investments is $26.96B USD. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for a net cash/debt picture and with total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
NVO
Currently viewingRevenueSwitch metric
Latest period
$26.96B
YoY change
+2.5%
5Y CAGR
+66.7%
Peak year (2023)
$30.23B
Latest annual
$26.96B
Cash on Hand history chart for Novo Nordisk (NVO) from 1985 to 2025
Cash on Hand history table for Novo Nordisk (NVO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Cash on Hand | YoY |
|---|---|---|---|---|
| 2025 | $26.96B | +2.5% | ||
| 2024 | $26.31B | -13.0% | ||
| 2023 | $30.23B | +28.2% | ||
| 2022 | $23.57B | +34.8% | ||
| 2021 | $17.48B | +733.8% | ||
| 2020 | $2.10B | -9.8% | ||
| 2019 | $2.32B | -85.1% | ||
| 2018 | $15.64B | -17.0% | ||
| 2017 | $18.85B | -8.9% | ||
| 2016 | $20.70B | +1.1% | ||
| 2015 | $20.46B | +28.7% | ||
| 2014 | $15.90B | +9.9% | ||
| 2013 | $14.47B | -10.2% | ||
| 2012 | $16.11B | -8.0% | ||
| 2011 | $17.50B | +9.0% | ||
| 2010 | $16.05B | +25.1% | ||
| 2009 | $12.83B | +25.9% | ||
| 2008 | $10.18B | +37.9% | ||
| 2007 | $7.38B | +44.7% | ||
| 2006 | $5.10B | +1.7% | ||
| 2005 | $5.02B | +25.8% | ||
| 2004 | $3.99B | +28.8% | ||
| 2003 | $3.10B | +77.9% | ||
| 2002 | $1.74B | -42.9% | ||
| 2001 | $3.05B | +139.1% | ||
| 2000 | $1.28B | -35.4% | ||
| 1999 | $1.97B | +147.2% | ||
| 1998 | $798.68M | -28.9% | ||
| 1997 | $1.12B | -28.6% | ||
| 1996 | $1.57B | -47.6% | ||
| 1995 | $3.00B | -55.1% | ||
| 1994 | $6.68B | +17.1% | ||
| 1993 | $5.71B | -1.9% | ||
| 1992 | $5.82B | -3.6% | ||
| 1991 | $6.04B | +39.1% | ||
| 1990 | $4.34B | +47.2% | ||
| 1989 | $2.95B | +16.9% | ||
| 1988 | $2.52B | +23.1% | ||
| 1987 | $2.05B | +2.7% | ||
| 1986 | $1.99B | -5.3% | ||
| 1985 | $2.11B | — |
Cash on Hand values are taken from Novo Nordisk's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in DKK as filed.
Analysis
2025's annual cash and short-term investments for Novo Nordisk (NVO) came in at $26.96B – edged up 2.5% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Novo Nordisk cash and short-term investments compounded at +66.7% per year, with the latest reading among the more recent periods of the dataset.
Novo Nordisk cash and short-term investments peaked at $30.23B in 2023; the latest annual figure is $26.96B in 2025 (10.8% below peak).
$30.23B stands as the all-time-high annual cash and short-term investments, posted in 2023, against a low of $798.68M during 1998.
Novo Nordisk (NVO) sits 2nd of 8 Healthcare peers we track on this metric, against a peer median of $9.62B.
Novo Nordisk Cash on Hand by Year
Novo Nordisk Cash on Hand 2025: $26.96B
Novo Nordisk cash and short-term investments in 2025 was $26.96B, edged up 2.5% from 2024.
Novo Nordisk Cash on Hand 2024: $26.31B
Novo Nordisk cash and short-term investments in 2024 was $26.31B, declined 13.0% below 2023.
Novo Nordisk Cash on Hand 2023: $30.23B
Novo Nordisk cash and short-term investments in 2023 was $30.23B, grew 28.2% from 2022. This figure represents the highest annual value in the available history.
Novo Nordisk Cash on Hand 2022: $23.57B
Novo Nordisk cash and short-term investments in 2022 was $23.57B, surged 34.8% from 2021.
Novo Nordisk Cash on Hand 2021: $17.48B
Novo Nordisk cash and short-term investments in 2021 was $17.48B.
See more financial history for Novo Nordisk (NVO).
Sector peers — Cash on Hand
Companies in the same sector as Novo Nordisk, ranked by their latest cash and short-term investments.
| Company | Cash on Hand | Sector |
|---|---|---|
| UnitedHealth Group Incorporated (UNH) | $28.12B | Healthcare |
| Johnson & Johnson (JNJ) | $20.10B | Healthcare |
| Merck & Co., Inc. (MRK) | $14.56B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $10.11B | Healthcare |
| Amgen Inc. (AMGN) | $9.13B | Healthcare |
| Eli Lilly and Company (LLY) | $7.27B | Healthcare |
| AstraZeneca PLC (AZN) | $5.74B | Healthcare |
| AbbVie Inc. (ABBV) | $5.26B | Healthcare |
Frequently asked questions
What is Novo Nordisk's cash and short-term investments?
- Latest reported cash and short-term investments for Novo Nordisk (NVO) is $26.96B (period ending December 31, 2025).
How has Novo Nordisk cash and short-term investments changed year-over-year?
- Novo Nordisk (NVO) cash and short-term investments changed +2.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Novo Nordisk cash and short-term investments?
- Novo Nordisk (NVO) cash and short-term investments compound annual growth rate is +66.7% over the most recent 5 years available.
When did Novo Nordisk cash and short-term investments hit its highest annual value?
- Novo Nordisk cash and short-term investments reached its highest annual value of $30.23B in 2023.
What was Novo Nordisk cash and short-term investments in 2024?
- Novo Nordisk (NVO) cash and short-term investments in 2024 was $26.31B.
What was Novo Nordisk cash and short-term investments in 2025?
- Novo Nordisk (NVO) cash and short-term investments in 2025 was $26.96B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
NVO Overview
Company profile, financial tools, and key metrics
NVO Revenue Counter
Earns 9,800 DKK every second. See per minute, hour, and day.
NVO Earnings Counter
Earns 3,248 DKK per second net profit. See per minute, hour, and day.
NVO What If Invested
What if you had invested $1,000? See historical returns from any date.
NVO How It Makes Money
Discover visual breakdown of 309.06B DKK in revenue — where it comes from and where it goes.
NVO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
NVO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
NVO Daily Price Character
Balanced · 47.3% historical win rate (green days). Streaks & record days.
NVO Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
NVO Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
NVO Dividend Profile
Yield: 4.62%. Safety: 5/8. See full history.
NVO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
NVO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.